EUVIMEDEUVIMED entdecken
Open Access

Selective kidney targeting increases the efficacy of mesenchymal stromal/stem cells for alleviation of murine stenotic‐kidney senescence and damage

Seo Rin Kim iD, Kai Jiang, Xiaojun Chen, Amrutesh S Puranik, Xiang-Yang Zhu, Amir Lerman, Tamara Tchkonia, James L Kirkland, Lilach O Lerman iD

Journal of Tissue Engineering and Regenerative Medicine · 2022-06 · 16 (6) · 550-558

DOI: 10.1002/term.3299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Tissue Engineering and Regenerative Medicine, online erschienen am 23.03.2022. Verfasst von Seo Rin Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Renal Artery Obstruction. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIA NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsRenal Artery ObstructionAnimalsCellular SenescenceCyclin-Dependent Kinase Inhibitor p16IschemiaKidneyMiceMice, Transgenic

Stichwörter der Autor:innen

cellular senescencekidney injury molecule-1mesenchymal stem cellsrenal artery stenosis

Substanzen

Cyclin-Dependent Kinase Inhibitor p16

Autor:innen und Institutionen

  • Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Internal Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University School of Medicine and Pusan National University Yangsan Hospital, Yangsan, Korea.
  • Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Department of Cardiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Seo Rin Kim, Lilach O Lerman

Förderung

  • NIDDK NIH HHS
  • NIA NIH HHS
  • National Institutes of Health

Zitieren

APA

Kim, S. R., Jiang, K., Chen, X., Puranik, A. S., Zhu, X. Y., Lerman, A., Tchkonia, T., Kirkland, J. L., & Lerman, L. O. (2022). Selective kidney targeting increases the efficacy of mesenchymal stromal/stem cells for alleviation of murine stenotic‐kidney senescence and damage. Journal of Tissue Engineering and Regenerative Medicine, 16(6), 550-558. https://doi.org/10.1002/term.3299

Vancouver

Kim SR, Jiang K, Chen X, Puranik AS, Zhu XY, Lerman A, et al. Selective kidney targeting increases the efficacy of mesenchymal stromal/stem cells for alleviation of murine stenotic‐kidney senescence and damage. Journal of Tissue Engineering and Regenerative Medicine. 2022;16(6):550-558. doi:10.1002/term.3299

BibTeX
@article{Kim2022,
  author = {Kim, Seo Rin and Jiang, Kai and Chen, Xiaojun and Puranik, Amrutesh S and Zhu, Xiang-Yang and Lerman, Amir and Tchkonia, Tamara and Kirkland, James L and Lerman, Lilach O},
  title = {Selective kidney targeting increases the efficacy of mesenchymal stromal/stem cells for alleviation of murine stenotic‐kidney senescence and damage},
  journal = {Journal of Tissue Engineering and Regenerative Medicine},
  year = {2022},
  volume = {16},
  number = {6},
  pages = {550--558},
  doi = {10.1002/term.3299}
}
Kostenlos starten →